Background and aims Hypertrophic cardiomyopathy (HCM) has various aetiologies, including genetic conditions like Fabry ...
Benefiting from technological and conceptual groundwork and positive early data, gene therapies are advancing in the clinic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback